Clinical Trial Update: Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients

View source ↗

Summary

This entry provides a clinical trial update on prophylactic therapy for cytomegalovirus in liver transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Snippet

Sponsor: Oregon Health and Science University | Conditions: Liver Transplantation | Status: UNKNOWN